Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

Analysis of Profitability Ratios

Microsoft Excel

Profitability Ratios (Summary)

Boston Scientific Corp., profitability ratios

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Return on Sales
Gross profit margin 68.81% 68.78% 65.05% 70.98% 71.37%
Operating profit margin 13.00% 10.09% -0.81% 14.14% 15.33%
Net profit margin 5.50% 8.76% -0.83% 43.78% 17.01%
Return on Investment
Return on equity (ROE) 3.97% 6.26% -0.54% 33.87% 19.15%
Return on assets (ROA) 2.15% 3.23% -0.27% 15.38% 7.96%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Boston Scientific Corp. gross profit margin ratio improved from 2020 to 2021 and from 2021 to 2022.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Boston Scientific Corp. operating profit margin ratio improved from 2020 to 2021 and from 2021 to 2022.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Boston Scientific Corp. net profit margin ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Boston Scientific Corp. ROE improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.
ROA A profitability ratio calculated as net income divided by total assets. Boston Scientific Corp. ROA improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.

Gross Profit Margin

Boston Scientific Corp., gross profit margin calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Gross profit 8,727 8,177 6,448 7,620 7,011
Net sales 12,682 11,888 9,913 10,735 9,823
Profitability Ratio
Gross profit margin1 68.81% 68.78% 65.05% 70.98% 71.37%
Benchmarks
Gross Profit Margin, Competitors2
Abbott Laboratories 51.54% 52.21% 50.49% 52.46%
Cigna Group 12.44% 12.41% 14.43% 15.57%
CVS Health Corp. 16.62% 17.48% 18.01% 17.41%
Elevance Health Inc. 16.79% 17.09% 19.71% 18.77%
Intuitive Surgical Inc. 67.44% 69.32% 65.65% 69.45%
Medtronic PLC 67.98% 65.19% 67.41% 70.04%
UnitedHealth Group Inc. 24.09% 23.60% 25.62% 23.19%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Gross profit margin = 100 × Gross profit ÷ Net sales
= 100 × 8,727 ÷ 12,682 = 68.81%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Boston Scientific Corp. gross profit margin ratio improved from 2020 to 2021 and from 2021 to 2022.

Operating Profit Margin

Boston Scientific Corp., operating profit margin calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Operating income (loss) 1,649 1,199 (80) 1,518 1,506
Net sales 12,682 11,888 9,913 10,735 9,823
Profitability Ratio
Operating profit margin1 13.00% 10.09% -0.81% 14.14% 15.33%
Benchmarks
Operating Profit Margin, Competitors2
Abbott Laboratories 19.16% 19.56% 15.48% 14.21%
Cigna Group 4.69% 4.60% 5.12% 5.31%
CVS Health Corp. 2.41% 4.54% 5.19% 4.69%
Elevance Health Inc. 4.94% 5.15% 4.97% 5.49%
Humana Inc. 4.11% 3.80% 6.56% 4.96%
Intuitive Surgical Inc. 25.35% 31.89% 24.09% 30.69%
Medtronic PLC 18.15% 14.89% 16.57% 20.51%
UnitedHealth Group Inc. 8.83% 8.40% 8.76% 8.19%
Operating Profit Margin, Sector
Health Care Equipment & Services 6.23% 6.69% 7.04% 6.89%
Operating Profit Margin, Industry
Health Care 13.52% 13.78% 10.30% 12.31%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Operating profit margin = 100 × Operating income (loss) ÷ Net sales
= 100 × 1,649 ÷ 12,682 = 13.00%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Boston Scientific Corp. operating profit margin ratio improved from 2020 to 2021 and from 2021 to 2022.

Net Profit Margin

Boston Scientific Corp., net profit margin calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Net income (loss) 698 1,041 (82) 4,700 1,671
Net sales 12,682 11,888 9,913 10,735 9,823
Profitability Ratio
Net profit margin1 5.50% 8.76% -0.83% 43.78% 17.01%
Benchmarks
Net Profit Margin, Competitors2
Abbott Laboratories 15.88% 16.42% 12.99% 11.56%
Cigna Group 3.72% 3.11% 5.31% 3.35%
CVS Health Corp. 1.29% 2.72% 2.68% 2.59%
Elevance Health Inc. 3.87% 4.46% 3.78% 4.66%
Humana Inc. 3.03% 3.54% 4.43% 4.20%
Intuitive Surgical Inc. 21.25% 29.85% 24.33% 30.80%
Medtronic PLC 15.90% 11.97% 16.56% 15.16%
UnitedHealth Group Inc. 6.25% 6.06% 6.03% 5.76%
Net Profit Margin, Sector
Health Care Equipment & Services 4.60% 4.96% 5.21% 4.85%
Net Profit Margin, Industry
Health Care 10.55% 11.48% 7.64% 10.09%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Net profit margin = 100 × Net income (loss) ÷ Net sales
= 100 × 698 ÷ 12,682 = 5.50%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Boston Scientific Corp. net profit margin ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.

Return on Equity (ROE)

Boston Scientific Corp., ROE calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Net income (loss) 698 1,041 (82) 4,700 1,671
Stockholders’ equity 17,573 16,622 15,326 13,877 8,726
Profitability Ratio
ROE1 3.97% 6.26% -0.54% 33.87% 19.15%
Benchmarks
ROE, Competitors2
Abbott Laboratories 18.90% 19.75% 13.71% 11.86%
Cigna Group 14.86% 11.39% 16.81% 11.26%
CVS Health Corp. 5.84% 10.54% 10.35% 10.39%
Elevance Health Inc. 16.59% 16.93% 13.77% 15.15%
Humana Inc. 18.33% 18.24% 24.53% 22.49%
Intuitive Surgical Inc. 11.98% 14.32% 10.90% 16.69%
Medtronic PLC 9.59% 7.01% 9.44% 9.25%
UnitedHealth Group Inc. 25.87% 24.09% 23.52% 24.02%
ROE, Sector
Health Care Equipment & Services 15.36% 15.06% 15.16% 14.26%
ROE, Industry
Health Care 22.88% 24.08% 15.82% 20.90%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
ROE = 100 × Net income (loss) ÷ Stockholders’ equity
= 100 × 698 ÷ 17,573 = 3.97%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Boston Scientific Corp. ROE improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.

Return on Assets (ROA)

Boston Scientific Corp., ROA calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Net income (loss) 698 1,041 (82) 4,700 1,671
Total assets 32,469 32,229 30,777 30,565 20,999
Profitability Ratio
ROA1 2.15% 3.23% -0.27% 15.38% 7.96%
Benchmarks
ROA, Competitors2
Abbott Laboratories 9.31% 9.40% 6.20% 5.43%
Cigna Group 4.63% 3.46% 5.44% 3.28%
CVS Health Corp. 1.82% 3.39% 3.11% 2.98%
Elevance Health Inc. 5.86% 6.26% 5.28% 6.21%
Humana Inc. 6.52% 6.61% 9.63% 9.31%
Intuitive Surgical Inc. 10.19% 12.58% 9.50% 14.17%
Medtronic PLC 5.54% 3.87% 5.28% 5.16%
UnitedHealth Group Inc. 8.19% 8.15% 7.81% 7.96%
ROA, Sector
Health Care Equipment & Services 5.63% 5.63% 5.61% 5.18%
ROA, Industry
Health Care 8.60% 8.69% 5.36% 7.15%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
ROA = 100 × Net income (loss) ÷ Total assets
= 100 × 698 ÷ 32,469 = 2.15%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. Boston Scientific Corp. ROA improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.